HANSA BIOPHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.62 SEK | +5.22% |
|
+5.81% | +16.87% |
| Apr. 18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
| Apr. 18 | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 170M | - | |||||
| 46.4B | - | |||||
| 41.75B | ||||||
| 41.37B | ||||||
| 29.71B | ||||||
| 26.01B |
- Stock Market
- Equities
- HNSA Stock
- Charts Hansa Biopharma AB
- Sector Chart